Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer (Q45287941)
Jump to navigation
Jump to search
scientific article published on 28 February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer |
scientific article published on 28 February 2005 |
Statements
1 reference
Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer (English)
1 reference
Philippe Beuzeboc
1 reference
Stéphane Oudard
1 reference
Eugeniu Banu
1 reference
Eric Voog
1 reference
Louis Marie Dourthe
1 reference
Anne Claire Hardy-Bessard
1 reference
Claude Linassier
1 reference
Florian Scotté
1 reference
Adela Banu
1 reference
Yvan Coscas
1 reference
François Guinet
1 reference
Marie-France Poupon
1 reference
Jean-Marie Andrieu
1 reference
28 February 2005
1 reference
1 reference
23
1 reference
15
1 reference
3343-3351
1 reference
Identifiers
1 reference
1 reference